ArticleJournal of materials science. Materials in medicine2025
Biofunctional semi-interpenetrating gellan gum and silk sericin scaffolds encapsulated with betel leaf extract-β-Cyclodextrin inclusive complexes for wound healing.
Article in Journal of materials science. Materials in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chronic wound treatment presents a significant challenge, requiring bioactive scaffolds that facilitate effective wound repair and promote skin regeneration with normal functionality. In this study, gellan gum (GG) networks were formed via physical crosslinking with divalent cations, while silk sericin (SS), as the linear phase, molecularly penetrated the pore volume of the GG network, resulting in the formation of semi-interpenetrating polymeric networks (semi-IPNs). The GG/SS scaffolds were enriched with betel leaf extract-encapsulated β-cyclodextrin complexes (B-ICs) to preserve the bioactive substance, improve the controlled release, and provide antibacterial, antioxidant and anti-inflammatory properties. Characterization through XRD, FTIR, and thermal analyses confirmed successful encapsulation and enhanced thermal stability, while SEM imaging revealed well-formed microporous structures. Mechanical testing showed that B-ICs significantly improved the compressive modulus and strength of the scaffolds. Additionally, the controlled release behavior of the B-ICs-GG/SS scaffolds, confirmed by the Korsmeyer-Peppas model, suggested anomalous transport as the release mechanism, aligning with the faster in vitro degradation rate. The scaffolds exhibited high phenolic content, resulting in excellent free radical scavenging activity to minimize oxidative stress and support an optimal wound healing environment. In vivo skin irritation test in rabbits confirmed that B-ICs-GG/SS scaffolds were non-irritant, suggesting the dermal safety and biocompatibility of the materials, a critical requirement for clinical translation. As a result, the B-ICs-GG/SS scaffolds would be a promising candidate for wound healing and tissue engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.